Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Intervalo de ano de publicação
1.
An Bras Dermatol ; 86(4 Suppl 1): S160-3, 2011.
Artigo em Inglês, Português | MEDLINE | ID: mdl-22068800

RESUMO

Basal Cell Carcinoma is the most common skin cancer. We describe a single-staged technique for correction of nasal ala defect after the excision of a basal cell carcinoma. This technique allows correction of surgical defects of the ala rebuilding the original anatomy, maintaining cosmetic units, without need for a graft.


Assuntos
Carcinoma Basocelular/cirurgia , Neoplasias Nasais/cirurgia , Rinoplastia/métodos , Neoplasias Cutâneas/cirurgia , Retalhos Cirúrgicos , Feminino , Humanos , Pessoa de Meia-Idade , Nariz/cirurgia
2.
An. bras. dermatol ; 86(4,supl.1): 160-163, jul,-ago. 2011. ilus
Artigo em Português | LILACS | ID: lil-604149

RESUMO

O Carcinoma Basocelular é a neoplasia cutânea mais frequente. Os autores descrevem uma técnica realizada unicamente num tempo operatório para correção de defeitos na asa do nariz após excisão tumoral. Esta técnica simples permite a correção cirúrgica de defeitos nesta localização possibilitando a reconstrução da anatomia local e a preservação das unidades cosméticas, sem a necessidade de enxerto.


Basal Cell Carcinoma is the most common skin cancer. We describe a single-staged technique for correction of nasal ala defect after the excision of a basal cell carcinoma. This technique allows correction of surgical defects of the ala rebuilding the original anatomy, maintaining cosmetic units, without need for a graft.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Carcinoma Basocelular/cirurgia , Neoplasias Nasais/cirurgia , Rinoplastia/métodos , Retalhos Cirúrgicos , Neoplasias Cutâneas/cirurgia , Nariz/cirurgia
4.
Mov Disord ; 22(10): 1471-1475, 2007 Jul 30.
Artigo em Inglês | MEDLINE | ID: mdl-17516496

RESUMO

Our objective was to evaluate the frequency of neoplastic and preneoplastic skin lesions in Parkinson's disease (PD) patients when compared with an aged-matched population. We performed a cross-sectional survey in PD patients and in an age-matched control group. Patients and controls were examined by a movement disorder specialist and a dermatologist. 150 PD patients and 146 controls were included. Thirty-five PD patients (23.3%) presented skin lesions that could be classified as neoplastic or preneoplastic vs. 20 subjects in the control group (13.7%) (OR 95%, CI 1.92 [1.05, 3.51]). However, this difference lost statistical significance when adjusted for gender (recruitment of controls was matched just for age with an over representation of males in the PD group). Twenty-nine PD patients (19%) presented actinic keratosis and basal cell carcinoma was diagnosed in 4 patients (3%). Although nonconclusive, our results are in agreement with previous studies suggesting an increased risk of skin cancer in PD patients. The frequency of actinic keratosis in PD patients and the associated risk to develop melanoma recommends its screening in future epidemiological studies.


Assuntos
Doença de Parkinson/fisiopatologia , Lesões Pré-Cancerosas/fisiopatologia , Neoplasias Cutâneas/fisiopatologia , Idoso , Estudos de Casos e Controles , Intervalos de Confiança , Estudos Cross-Over , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Fatores de Risco , Inquéritos e Questionários
5.
J Am Acad Dermatol ; 55(6): 968-74, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17097393

RESUMO

BACKGROUND: Glatiramer acetate has been shown to be effective in reducing the relapse and improving the disability of patients with multiple sclerosis. The most common adverse effects at the injection sites include pain, inflammation, and induration that spontaneously disappear within hours or a few days. OBJECTIVE: We sought to characterize the histopathologic findings of localized panniculitis induced by glatiramer acetate at the injection sites. METHODS: Seven patients receiving daily glatiramer acetate injections for treatment of multiple sclerosis developed localized panniculitis at the injection sites. The lesions were histopathologically and immunohistochemically studied. RESULTS: The lesions consisted of a mostly lobular panniculitis, with lipophagic granuloma, namely histiocytes engulfing the lipids from necrotic adipocytes. In many areas, scattered neutrophils and eosinophils were seen both in the septa and in the fat lobules. Connective tissue septa showed widening and fibrosis in conjunction with many lymphoid follicles, presenting with germinal center formation. Immunohistochemically, the inflammatory infiltrate of the fat lobule consisted of CD68+ histiocytes and suppressor/cytotoxic T lymphocytes. In contrast, the lymphoid follicles in the septa and at the interface between septum and fat lobule were mainly composed of B lymphocytes. LIMITATIONS: Only one biopsy was performed in each patient and, therefore, it was not possible to study the histopathologic evolution of the panniculitic process. CONCLUSIONS: Localized panniculitis at the sites of subcutaneous injections of glatiramer acetate for treatment of multiple sclerosis seems to be a rare, but characteristic side effect of this therapy. The histopathologic pattern of these lesions consists of a mostly lobular panniculitis, with histiocytes and T lymphocytes in the fat lobule and thickened septa with scattered lymphoid follicles, which are mostly composed of B lymphocytes.


Assuntos
Imunossupressores/efeitos adversos , Esclerose Múltipla/tratamento farmacológico , Paniculite/induzido quimicamente , Peptídeos/efeitos adversos , Adipócitos/patologia , Adulto , Antígenos de Diferenciação/análise , Atrofia , Linfócitos B/patologia , Biópsia , Eritema/induzido quimicamente , Feminino , Centro Germinativo/imunologia , Centro Germinativo/patologia , Acetato de Glatiramer , Granuloma/induzido quimicamente , Granuloma/imunologia , Granuloma/patologia , Histiócitos/patologia , Humanos , Hiperpigmentação/induzido quimicamente , Técnicas Imunoenzimáticas , Imunossupressores/administração & dosagem , Injeções Subcutâneas/efeitos adversos , Tecido Linfoide/patologia , Pessoa de Meia-Idade , Necrose , Dor/etiologia , Paniculite/imunologia , Paniculite/patologia , Peptídeos/administração & dosagem , Subpopulações de Linfócitos T/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA